Piero Ruggenenti

6PUBLICATIONS
27CO-AUTHORS
Cross-sectional analysisRespiratory diseasesEpidemiological modellingBiologically active moleculesMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 19, 2026
Glomerular filtration rate estimation in nephrotic patients: creatinine and/or cystatin-C-based equations, or none of them?

|Dec 20, 2021
Eculizumab in patients with severe coronavirus disease 2019 (COVID-19) requiring continuous positive airway pressure ventilator support: Retrospective cohort study.

Piero Ruggenenti, Fabiano Di Marco, Monica Cortinovis

|Oct 14, 2021
Glomerular resistances predict long-term GFR decline in type 2 diabetic patients without overt nephropathy: a longitudinal subgroup analysis of the DEMAND trial.

Fabiola Carrara, Piero Ruggenenti, Annalisa Perna

|Jul 14, 2021
Preventing microalbuminuria with benazepril, valsartan, and benazepril-valsartan combination therapy in diabetic patients with high-normal albuminuria: A prospective, randomized, open-label, blinded endpoint (PROBE) study.

Piero Ruggenenti, Monica Cortinovis, Aneliya Parvanova

|Jun 24, 2021
Mycophenolate mofetil versus azathioprine in kidney transplant recipients on steroid-free, low-dose cyclosporine immunosuppression (ATHENA): A pragmatic randomized trial.

Piero Ruggenenti, Paolo Cravedi, Eliana Gotti

|Apr 06, 2019
Octreotide-LAR in later-stage autosomal dominant polycystic kidney disease (ALADIN 2): A randomized, double-blind, placebo-controlled, multicenter trial.

Norberto Perico, Piero Ruggenenti, Annalisa Perna

Pageof 1

Frequent Collaborators

5 joint publications

Giuseppe Remuzzi

4 joint publications

Annalisa Perna

3 joint publications

Matias Trillini

3 joint publications

Flavio Gaspari